Rebel Foods
Venture Round in 2025
Rebel Foods operates cloud kitchens that deliver food on demand through various in-house brands. It combines culinary expertise with advanced technology to enhance food quality and delivery efficiency, focusing on different consumer dining occasions.
Lomond Therapeutics
Venture Round in 2025
Lomond Therapeutics is a pharmaceutical company specializing in the discovery and development of small molecule inhibitors targeting escape variants in hematologic malignancies.
Supira Medical
Series E in 2025
Supira Medical develops a percutaneous ventricular assist device (pVAD) designed to provide temporary mechanical support during high-risk coronary interventions and cardiogenic shock. Its solution assists the native pumping action of the heart, enabling patients to undergo necessary procedures.
Arbor Biotechnologies
Series C in 2025
Arbor Biotechnologies, Inc., founded in 2016 and headquartered in Cambridge, Massachusetts, operates as a bio-discovery company in the biotechnology sector. The company focuses on developing genomic tools that enhance human health and sustainability. Utilizing a combination of artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening, Arbor's platform accelerates the discovery of proteins and facilitates human diagnostic development. The technology aggregates genomic sequence data through AI and machine learning, enabling drug developers to replace entire genes and precisely correct mutations. This approach aims to streamline the development of curative treatments for previously incurable genetic diseases, ultimately improving the lives of patients affected by such conditions.
Latigo Biotherapeutics
Series B in 2025
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain. The company aims to target pain at its source to provide effective, rapid-acting pain relief without the risk of addiction. Their lead program targets Nav1.8, a validated human pain target, leveraging internal ion channel expertise.
Voldex develops and operates a user-generated content game platform that enables creators to build, host, and monetize experiences across popular titles such as Roblox, Fortnite Creative, and Minecraft. The company provides game development, community engagement, and monetization tools, helping creators reach millions of players worldwide. Founded in 2015, Voldex has a global team of about 60 full-time professionals and is among the leading developers in the UGC games space with several top games and substantial monthly engagement.
Instabase
Series D in 2025
Instabase, Inc. is a technology company based in San Francisco, California, founded in 2015. It specializes in developing a platform that automates document processing workflows and analyzes unstructured data. The platform integrates various capabilities, including optical character recognition, data classification and extraction, and natural language processing, allowing organizations across sectors such as insurance, finance, and healthcare to streamline operations and improve decision-making. Additionally, Instabase provides a developer kit that enables the creation of customized business applications, helping institutions embed artificial intelligence into their systems and processes. Through its innovative solutions, Instabase aims to address significant business challenges and facilitate transformational outcomes for its clients.
Databricks
Series J in 2024
Databricks offers a unified data analytics platform that simplifies data integration, enables real-time experimentation, and facilitates robust deployment of production applications for developers and data scientists. Serving diverse industries worldwide, Databricks' platform supports collaborative data science, machine learning workflows, and integrates with various cloud services.
Audi AG
Private Equity Round in 2024
Audi AG is a leading manufacturer of premium vehicles known for their sporty performance, high build quality, and innovative design, encapsulated in their motto “Vorsprung durch Technik.” As a subsidiary of the luxury automotive segment, Audi produces a diverse array of luxury cars that cater to discerning customers. The company is committed to evolving the automotive landscape by actively participating in the transition toward new forms of mobility, systematically implementing strategic initiatives to ensure its relevance in the changing market.
XAI is a technology company specializing in artificial intelligence. It creates and deploys AI solutions, primarily using machine learning, to enhance data analysis and decision-making processes. XAI caters to the finance, healthcare, and logistics sectors, aiming to improve accuracy and efficiency in these industries.
Cresta is a technology company that leverages artificial intelligence to enhance customer service and sales operations. Its platform is designed to improve the quality of customer interactions by providing timely and relevant information to agents, thereby facilitating effective communication between agents and customers. By augmenting the capabilities of sales and service teams, Cresta's tools aim to increase conversion rates and overall efficiency, ultimately enabling businesses to significantly boost productivity in their customer-facing operations. Through its innovative approach, Cresta supports organizations in managing inquiries more effectively and streamlining their customer experience.
Beta Technologies
Series C in 2024
Beta Technologies designs and develops electric aircraft and related systems, including propulsion, energy storage, and flight control technologies, with a focus on clean aviation. It builds integrated solutions to enable scalable electric flight, including charging infrastructure and pilot training tools for cargo, medical, passenger, and defense applications, and supports a self-sufficient eVTOL ecosystem that aims to improve access to vertical mobility for logistics and healthcare transport.
ONE Championship
Venture Round in 2024
ONE Championship is Asia's largest sports media property with a global broadcast to over 1 billion potential viewers across 128 countries. Headquartered in Singapore, the world’s most exciting martial arts organization is home to some of the greatest martial artists in the world, hosting Asia's greatest sports entertainment events in the largest stadiums of the most iconic cities across the region.
TechMet
Private Equity Round in 2024
TechMet Limited is a private industrial company based in Dublin, Ireland, established in 2017. It focuses on securing the supply of key technology metals essential for advanced technologies, including electric vehicles, renewable energy systems, and energy storage devices. The company engages in various stages of the metal supply chain, encompassing mining, processing, refining, and recycling. TechMet's portfolio includes interests in production and development assets located in Africa, North America, and South America. By addressing supply chain challenges associated with critical metals such as nickel, cobalt, lithium, rare earth metals, vanadium, tungsten, and tin, TechMet aims to ensure a stable and sustainable supply that supports the growing demand from emerging technologies.
Outpace Bio
Series B in 2024
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.
Bright Peak Therapeutics
Series C in 2024
Bright Peak Therapeutics is a biotechnology company focused on developing a range of immunotherapies aimed at treating cancer and autoimmune diseases. The company specializes in creating immuno-cytokines that possess pharmacological properties enabling tissue and cell-specific targeting of cytokine payloads. This innovative approach is designed to enhance the efficacy of treatments, ultimately improving patient outcomes and quality of life. By leveraging its expertise in cytokine therapeutics, Bright Peak aims to advance the field of immunotherapy and provide effective solutions for challenging medical conditions.
Isotopen Technologien München
Private Equity Round in 2024
ITM Isotopen Technologien München AG is a biotechnology and radiopharmaceutical company based in Garching, Germany, focusing on the development, manufacturing, and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radionuclides for cancer treatment. Established in 2004, ITM has built a robust global supply network and accomplished GMP manufacturing capabilities. The company offers a range of products, including EndolucinBeta, a radiopharmaceutical precursor for targeted radionuclide therapy, as well as radionuclides like 225Ac and 213Bi. Additionally, ITM develops automated systems for synthesizing radiolabeled biomolecules and provides GMP radiolabeling services. With a growing portfolio of innovative treatments and partnerships, ITM aims to enhance patient outcomes and quality of life in oncology, specifically addressing conditions such as neuroendocrine cancers and bone metastases while minimizing side effects.
Iambic Therapeutics focuses on accelerating molecular discovery through its innovative quantum molecular simulation engine. By integrating artificial intelligence and automated synthetic development, the company aims to enhance the design of small-molecule therapeutics. This technology significantly improves the accuracy of molecular predictions, providing valuable insights for therapeutic discovery. Iambic Therapeutics is committed to transforming the drug development process, enabling physicians to access more precise molecular data and ultimately improving treatment outcomes.
Kingdee is a prominent Chinese software company specializing in management and cloud services. It offers a comprehensive range of solutions, including enterprise resource planning (ERP), financial cloud services for small and micro businesses, and industry-specific cloud services. Kingdee's core business revolves around the development and sales of software products, along with providing software implementation, consulting, maintenance, and upgrade services. The company serves over one million clients, including enterprises and government organizations, and has established a significant presence in China's software market, being recognized as the leader in small and medium enterprise software solutions for nine consecutive years. With a vast network of over 2,000 partners, Kingdee continues to innovate and expand its offerings in the digital management space, making it a key player in the industry.
Clove Dental
Series E in 2023
Clove Dental operates a network of multi-specialty dental clinics that provide a wide range of professional oral healthcare services. With over 350 clinics and a patient base exceeding 1 million each month, Clove Dental specializes in various treatments including endodontics, periodontics, orthodontics, prosthodontics, cosmetic dentistry, pediatric care, and oral and maxillofacial surgery. The company is committed to high standards of hygiene, clinic safety, and customer service, employing more than 800 dentists and utilizing advanced equipment and pain-management technologies to enhance patient experiences.
Canary Wharf Group
Private Equity Round in 2023
Canary Wharf Group has transformed the former Docklands into 97 acres of sought-after office and retail space. Its workforce of over 950 employees is organized across three subsidiaries: a development arm, a construction arm, and a management arm.
Precede Biosciences
Series A in 2023
Precede Biosciences is breaking down the barriers to precision medicine by redefining what can be gleaned from a simple blood draw. Precede aims to increase drug development success rates and to contribute to a future in which every patient can receive a speedy, minimally invasive diagnosis and therapy tailored to the biology of their condition.
Severn Trent is a UK-based water utility that supplies drinking water and manages wastewater services for homes and businesses. The company operates primarily in the United Kingdom, with additional activities in the United States and Europe, offering contract services to industrial and municipal clients to develop and operate water treatment facilities and distribution networks. It focuses on delivering regulated water and wastewater services while pursuing efficiency improvements, asset management, and environmental performance. Through its services arm, it provides water and wastewater management, leakage repair, water procurement and bill management, and water efficiency measures for private networks and commercial customers. The group also engages in renewable energy operations derived from hydropower, wind, and solar projects, supporting sustainable energy alongside core water services. With decades of experience, Severn Trent emphasizes client value through tailored solutions, long-term partnerships, and a focus on safeguarding water resources and reducing environmental impact.
BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. BridgeBio creates a bridge from advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible.
BridgeBio's mission is to discover, create, test, and deliver transformative medicines to treat patients with genetic diseases.
Databricks
Series I in 2023
Databricks offers a unified data analytics platform that simplifies data integration, enables real-time experimentation, and facilitates robust deployment of production applications for developers and data scientists. Serving diverse industries worldwide, Databricks' platform supports collaborative data science, machine learning workflows, and integrates with various cloud services.
Ascend Elements
Series D in 2023
Ascend Elements specializes in manufacturing advanced battery materials using recycled lithium-ion batteries. It employs hydroprocess recycling and direct recycling methods to create new cathode materials from old ones, contributing to a more sustainable electric vehicle industry.
Star Therapeutics
Series C in 2023
Star Therapeutics aims to develop therapies for numerous rare diseases by identifying those with shared biological pathways. This approach enables the creation of single treatments capable of addressing multiple conditions, thereby expanding pharmaceutical pipelines.
Reliance Industries Limited
Private Equity Round in 2023
Reliance Industries Limited is a diversified Indian conglomerate with activities spanning hydrocarbon exploration and production, refining and petrochemicals, and a broad set of consumer and business services. The group operates through five main segments: Oil to Chemicals, Oil and Gas, Retail, Digital Services, and other services. Its refining network produces fuels and petrochemical feedstock for global markets, while the Oil to Chemicals segment integrates refining with petrochemicals. In addition to energy and chemicals, Reliance pursues financial services, retail, and digital services to serve millions of customers in India. Reliance Retail operates a nationwide store network, including neighborhood outlets, supermarkets, hypermarkets, wholesale formats, specialty stores and online platforms, offering fresh foods, groceries, apparel, home goods, electronics, and farm implements, with a focus on backward integration from farmers to end consumers. The group is one of India's largest publicly traded companies by revenue and market capitalization, and its portfolio touches daily life for many Indians through energy, consumer products, and digital platforms.
Adani Enterprises
Post in 2023
Adani Enterprises is a diversified conglomerate within the Adani Group focusing on building infrastructural assets and nation-building. Its portfolio spans energy generation and logistics, including coal management, solar cell and module manufacturing, and electric power generation; it also supports agri-storage infrastructure and edible oils and food products. The group extends into natural gas through Adani Total Gas and its city gas distribution networks, and into aviation infrastructure via Adani Airport Holdings. Through Adani New Industries, the company pursues green hydrogen initiatives and the production of wind turbines, solar modules, batteries and electrolyzers. Adani Green Energy and Adani Power illustrate involvement in renewable and conventional power generation, while Adani Airports and related ventures provide airport development and services. The company emphasizes infrastructure-led growth across India.
Carsome
Venture Round in 2023
Carsome operates an online platform that connects sellers of used cars with dealers, offering inspection, valuation, bidding, and logistics to facilitate the entire selling process. The platform supports ownership transfer, financing options, and a curated selection of pre-owned cars for buyers, enabling relatively quick sales. Founded in 2015 and headquartered in Malaysia, Carsome has expanded to Indonesia, Thailand, and Singapore.
Isotopen Technologien München
Private Equity Round in 2023
ITM Isotopen Technologien München AG is a biotechnology and radiopharmaceutical company based in Garching, Germany, focusing on the development, manufacturing, and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radionuclides for cancer treatment. Established in 2004, ITM has built a robust global supply network and accomplished GMP manufacturing capabilities. The company offers a range of products, including EndolucinBeta, a radiopharmaceutical precursor for targeted radionuclide therapy, as well as radionuclides like 225Ac and 213Bi. Additionally, ITM develops automated systems for synthesizing radiolabeled biomolecules and provides GMP radiolabeling services. With a growing portfolio of innovative treatments and partnerships, ITM aims to enhance patient outcomes and quality of life in oncology, specifically addressing conditions such as neuroendocrine cancers and bone metastases while minimizing side effects.
SK On
Private Equity Round in 2023
SK On specializes in the development and manufacturing of high-energy density lithium-ion batteries for electric vehicles (EVs). By producing high-capacity, efficient batteries, they aim to reduce CO2 emissions globally.
Insider
Venture Round in 2023
Insider is a growth management platform that assists digital marketers in optimizing their strategies across the entire marketing funnel, from acquisition to retention and revenue generation. Founded in 2012 and headquartered in Singapore, the company utilizes advanced artificial intelligence and machine learning technologies to provide real-time predictive segmentation. This enables marketers to create personalized customer journeys across various channels, including web, mobile, and advertising platforms. Insider's unified data layer simplifies implementation and usage, reducing reliance on complex IT integrations. The platform is designed to minimize marketing waste by enhancing cross-channel customer experiences and optimizing return on ad spend. With a focus on delivering insights that enhance personalization efforts, Insider serves a diverse range of industries, including retail, finance, automotive, and travel, and has established a global presence with offices in multiple countries.
Builder.ai
Series D in 2023
Builder.ai is a software platform that simplifies the process of building and operating applications and websites through the use of artificial intelligence. Founded in January 2012 and headquartered in San Francisco, California, the company offers a solution that enables enterprises, small businesses, and entrepreneurs to create, manage, and scale their software projects without needing technical skills or programming knowledge. Its primary offering, Builder, manages the entire development process, while CloudOps provides automation, financial oversight, and transparency for cloud infrastructure management. This innovative approach allows users to efficiently navigate the complexities of software development, making it accessible to a wider audience.
OriCell Therapeutics
Series B in 2023
OriCell Therapeutics is a biopharmaceutical company that specializes in the development of innovative cellular drugs aimed at addressing unmet clinical needs in tumor immunotherapy. The company focuses on creating therapeutics for a range of cancers, including liver cancer, myeloma, ovarian cancer, gastric cancer, cervical cancer, and non-small cell lung cancer. With a commitment to effective and affordable treatment options, OriCell Therapeutics aims to enhance patient care through the development of clinically valuable therapies, seeking to establish itself as a leader in the field of novel oncological treatments.
Padam Graphics
Private Equity Round in 2023
Padam Graphics is a prominent manufacturer based in India, specializing in the production of various types of machinery for the packaging industry. The company focuses on Non Woven Bag Making Machines, Non Woven Printing Machines, Paper Bag Making Machines, Paper Cup Making Machines, and Paper Straw Making Machines. In addition to manufacturing, Padam Graphics also engages in importing and exporting these machines, catering to a diverse range of clients within the packaging sector.
Ensoma is a biotechnology company focused on advancing genomic medicine through its innovative in vivo approach, utilizing proprietary Engenious vectors. These vectors are engineered to deliver a wide array of gene modification technologies directly to blood and immune cells, including T cells, B cells, and myeloid cells, without the necessity for stem cell collection or prior myeloablative conditioning, which can pose risks to patients. This unique method allows for the administration of therapies via a single injection, enhancing accessibility and convenience in various healthcare settings, even where resources may be limited. Ensoma aims to expand the curative potential of genomic medicine, making it more accessible to patients in need.
Snyk Ltd., established in 2015, specializes in a Software as a Service (SaaS) platform that enhances application security. It focuses on identifying, rectifying, and monitoring known vulnerabilities across critical components of modern applications, including code, open-source libraries, containers, and infrastructure as code. Snyk's offerings, such as Snyk Code (static application security testing), container vulnerability management, and application security management, integrate seamlessly with developers' workflows, improving security posture, productivity, and collaboration. With over 1,200 global customers, including industry leaders like Google and Salesforce, Snyk is recognized for its developer-first approach and strategic partnerships.
SK On
Private Equity Round in 2022
SK On specializes in the development and manufacturing of high-energy density lithium-ion batteries for electric vehicles (EVs). By producing high-capacity, efficient batteries, they aim to reduce CO2 emissions globally.
THG Holdings plc is an online retailer and technology company based in Manchester, United Kingdom, specializing in direct-to-consumer e-commerce solutions for consumer brand owners. Founded in 2004, the company has developed a robust platform that enables the manufacture and online retail of nutrition, skincare, haircare, and cosmetics products. THG operates a diverse array of websites that sell luxury fashion items and provides various services, including website development, online advertising, marketing, and consultancy. Additionally, it offers warehousing, distribution, and content creation through THG Studios, which supports large-scale projects. Beyond e-commerce, THG is involved in the management of hairdressing salons, hotels, and health clubs. The company was previously known as The Hut Group Limited before rebranding to THG Holdings plc in September 2020.
BYJU'S
Funding Round in 2022
BYJU'S is a prominent global ed-tech company founded in India in 2011, dedicated to providing adaptive and engaging learning solutions to over 150 million students worldwide. The company aims to make high-quality education accessible to learners of all ages through its flagship product, BYJU's: The Learning App, and a diverse portfolio that includes brands such as Disney-BYJU's Early Learn, BYJU's FutureSchool, and WhiteHat Jr. BYJU'S employs personalized learning methodologies that cater to individual learning styles and paces, supported by a network of over 12,000 teachers. The platform utilizes original content, watch-and-learn videos, animations, and interactive simulations to create a contextual and practical learning experience. Additionally, BYJU'S has formed innovative partnerships with major companies like Disney and Google to enhance engagement. Headquartered in India, BYJU'S operates in more than 21 countries and offers programs in over 8 languages, further solidifying its position as a leader in the education technology sector.
InnovaFeed
Series D in 2022
InnovaFeed is a biotech company developing insect-based protein and oils from Hermetia illucens for animal feed and aquaculture. Leveraging a technology that places insects at the heart of the agri-food system, it recycles nutrients to provide sustainable protein for feeding fish, birds, and small mammals. The company offers natural, sustainable ingredients from insect rearing, including high-quality insect oil rich in lauric acid, which has antimicrobial properties and can substitute imported oils in poultry and swine feed, supporting a more sustainable food system and diversified protein supply.
JenaValve Technology
Series C in 2022
JenaValve Technology, Inc. is a medical device company specializing in the design, development, and manufacturing of transcatheter aortic valve replacement (TAVR) systems for patients with severe aortic regurgitation and aortic stenosis. Founded in 2006 and headquartered in Irvine, California, with additional locations in Munich, Germany, and Leeds, United Kingdom, the company focuses on providing innovative solutions for high-risk patients who may not be suitable candidates for traditional surgical aortic valve replacement. The company's flagship product, the Trilogy™ Heart Valve System, received CE Mark approval in May 2021 and is notable for its dual-disease treatment capabilities. JenaValve's TAVR systems feature a porcine pericardial trileaflet valve mounted on a low-profile nitinol self-expanding frame, designed to engage with the native valve structures for optimal performance. The company has also received Breakthrough Device Designation from the U.S. Food and Drug Administration to facilitate the review of its pivotal trial for the Trilogy Heart Valve System in the United States.
Celonis is a company that specializes in execution management, focusing on optimizing and analyzing business processes across various industries, including production, human resources, and logistics. Its core product, the Celonis Execution Management System (EMS), utilizes advanced process mining technology to enhance productivity and streamline operations. The EMS provides a comprehensive suite of tools and applications, including Celonis Studio, designed for business executives and users to effectively manage execution across analytics, strategy, planning, and automation. By offering unique software solutions, Celonis enables organizations to improve process transparency and efficiency, ultimately unlocking their full execution capacity.
Senda Biosciences
Series C in 2022
Senda Biosciences, founded in 2017 by David Kolesky, Ignacio Martinez, and John Casey in Cambridge, Massachusetts, focuses on developing therapeutic applications for innovative treatments of human diseases. The company specializes in studying the molecular relationships between bacterial, botanical, and human cells to understand how these interactions influence health and disease. By gaining insights into these interspecies connections, Senda Biosciences aims to create novel categories of medicines and delivery methods, providing medical professionals with new tools to combat various illnesses.
X (formerly Twitter)
Post in 2022
Twitter is a social networking platform that facilitates the exchange of micro-blogs, known as "tweets," which can be up to 280 characters in length. Launched in 2006, it allows users to send and read tweets through various means, including web browsers, SMS, and mobile applications. With over 400 million monthly visitors and 255 million active users, Twitter serves as a global real-time communications platform. Its diverse user base includes world leaders, athletes, entertainers, and news organizations, contributing to its role as a significant source of information and engagement. The platform is available in more than 35 languages and has a strong presence in major cities worldwide, with headquarters in San Francisco and offices across the United States and internationally.
Starling Bank
Series D in 2022
Starling Bank Limited is a digital-only bank based in London, United Kingdom, founded in 2014. It specializes in providing personal, joint, and business banking services through a mobile platform. The bank offers a range of financial services, including digital banking, real-time spending intelligence, and personalized banking options. Customers can manage their accounts entirely online, benefiting from features such as same-day payments and comprehensive financial management tools. Starling Bank aims to facilitate a seamless, paperless banking experience for its users.
BioXcel Therapeutics
Post in 2022
BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, that specializes in drug development using innovative artificial intelligence techniques. Founded in 2017, the company focuses on addressing significant unmet medical needs in the fields of neuroscience and immuno-oncology. Its leading product, BXCL501, is a sublingual thin film formulation of dexmedetomidine, approved for the acute treatment of agitation associated with schizophrenia and bipolar disorders. Another key asset, BXCL701, is an immuno-oncology agent targeting prostate and pancreatic cancers. BioXcel Therapeutics employs a unique drug re-innovation strategy that combines existing approved drugs with advanced data analytics and machine learning to identify new therapeutic opportunities, thereby aiming to streamline the drug development process. The company has established collaborations with prominent pharmaceutical firms to enhance its research and development efforts in oncology.
BioXcel Therapeutics
Post in 2022
BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, that specializes in drug development using innovative artificial intelligence techniques. Founded in 2017, the company focuses on addressing significant unmet medical needs in the fields of neuroscience and immuno-oncology. Its leading product, BXCL501, is a sublingual thin film formulation of dexmedetomidine, approved for the acute treatment of agitation associated with schizophrenia and bipolar disorders. Another key asset, BXCL701, is an immuno-oncology agent targeting prostate and pancreatic cancers. BioXcel Therapeutics employs a unique drug re-innovation strategy that combines existing approved drugs with advanced data analytics and machine learning to identify new therapeutic opportunities, thereby aiming to streamline the drug development process. The company has established collaborations with prominent pharmaceutical firms to enhance its research and development efforts in oncology.
Insider is a growth management platform that assists digital marketers in optimizing their strategies across the entire marketing funnel, from acquisition to retention and revenue generation. Founded in 2012 and headquartered in Singapore, the company utilizes advanced artificial intelligence and machine learning technologies to provide real-time predictive segmentation. This enables marketers to create personalized customer journeys across various channels, including web, mobile, and advertising platforms. Insider's unified data layer simplifies implementation and usage, reducing reliance on complex IT integrations. The platform is designed to minimize marketing waste by enhancing cross-channel customer experiences and optimizing return on ad spend. With a focus on delivering insights that enhance personalization efforts, Insider serves a diverse range of industries, including retail, finance, automotive, and travel, and has established a global presence with offices in multiple countries.
Advanced Integration Technology
Secondary Market in 2022
Advanced Integration Technology is an industrial automation and tooling company focused on serving the aerospace, defense, and space launch vehicle industries. It specializes in the design, manufacture, and installation of automated tooling and equipment used in the assembly of aerospace structures. By delivering turnkey factory integration solutions, the company employs lean and flexible automation techniques to optimize operations. With a proven track record, Advanced Integration Technology has successfully installed hundreds of systems globally, enabling clients to reduce costs, mitigate risks, and complete projects within tight timelines.
Ventus Therapeutics
Series C in 2022
Ventus Therapeutics is a biopharmaceutical company focused on discovering and developing innovative small molecule medicines that target the innate immune system. The company employs a structural immunology platform that provides deep insights into molecular structures and mechanisms, enabling precise targeting of the innate immune system. Ventus combines advanced protein engineering capabilities with cutting-edge rational and structure-based drug design tools to create therapeutics aimed at treating autoimmune diseases, inflammatory conditions, and cancer. The company is actively building a diverse pipeline of drug programs that address significant targets within the innate immune system, with the goal of advancing treatments for both acute and chronic inflammatory and immune-related diseases.
Swiggy
Venture Round in 2022
Swiggy is a consumer-focused technology company offering an integrated app for food ordering, grocery shopping, restaurant reservations, and event bookings. It facilitates doorstep delivery of these items via its network of on-demand delivery partners.
Checkout.com
Series D in 2022
Checkout.com is a company that specializes in providing an online payments platform designed to facilitate secure digital transactions across the Internet. Established in 2012, it offers a comprehensive solution that supports payments in over 150 currencies, integrating local acquiring capabilities and advanced fraud detection through a single API. The platform enables businesses to accept all major international credit and debit cards, as well as various alternative and local payment methods. With a focus on eliminating intermediaries, Checkout.com connects retailers directly with customers' bank accounts, delivering data-rich insights that help enhance performance and improve approval rates. The company employs more than 1,700 people across 19 offices globally, ensuring local expertise and tailored risk management solutions to help businesses optimize their mobile and online purchasing while effectively managing potential risks.
Carsome operates an online platform that connects sellers of used cars with dealers, offering inspection, valuation, bidding, and logistics to facilitate the entire selling process. The platform supports ownership transfer, financing options, and a curated selection of pre-owned cars for buyers, enabling relatively quick sales. Founded in 2015 and headquartered in Malaysia, Carsome has expanded to Indonesia, Thailand, and Singapore.
Space Perspective
Secondary Market in 2021
Space Perspective Inc. is a spaceflight company based in Merritt Island, Florida, founded in 2019. It specializes in offering high-altitude balloon trips to the edge of space through its innovative spaceship, Neptune. The company aims to provide unique space travel experiences for tourists, allowing them to witness the curvature of the Earth from a stratospheric altitude. Flights are launched from Florida's Space Coast, specifically from the historic runway used by the Space Shuttle. Space Perspective plans to expand its operations to additional launch sites, including Cecil Spaceport in Florida, Hawaii, and Alaska, among others. The pressurized capsule used for these flights ascends to approximately 100,000 feet, remains at that altitude for two hours, and then descends slowly under the balloon, ultimately splashing down in the ocean for retrieval.
Infarm is a Berlin-based company that specializes in building and distributing efficient vertical farms within urban environments. Founded in 2013, Infarm employs IoT technologies and machine learning to create a modular farming system designed to enhance food production. Its innovative approach allows cities to grow fresh produce locally, promoting self-sufficiency while improving the safety, quality, and environmental impact of food. By integrating advanced technology with compact growing kits, Infarm aims to provide a resilient and transparent alternative food system that meets the needs of urban populations.
ONE Championship
Venture Round in 2021
ONE Championship is Asia's largest sports media property with a global broadcast to over 1 billion potential viewers across 128 countries. Headquartered in Singapore, the world’s most exciting martial arts organization is home to some of the greatest martial artists in the world, hosting Asia's greatest sports entertainment events in the largest stadiums of the most iconic cities across the region.
Travelling Folks
Pre Seed Round in 2021
Travelling folks is a travel agency which is established in the year 2006 and is located in Jammu Kashmir India. In the l few years, we have been serving many clients We have been providing good quality service for all types of travelers.
We are committed to providing our customers with the best possible services. Our team of experts will assist you in finding the perfect holiday package according to your budget and preferences.
Rebel Foods
Series F in 2021
Rebel Foods operates cloud kitchens that deliver food on demand through various in-house brands. It combines culinary expertise with advanced technology to enhance food quality and delivery efficiency, focusing on different consumer dining occasions.
VerSe Innovation
Series I in 2021
VerSe Innovation is a local language technology company that develops a discovery platform to consume and socialize with media. Its platform facilitates the curation of content and tracks user preferences through its vertical search and recommendation tools that provide users with personalized content and notifications.
Trendyol
Private Equity Round in 2021
Founded in 2010, Trendyol is a leading Turkish e-commerce company offering a wide range of fashion products, including clothing, shoes, accessories, cosmetics, and home decorations. With over 2000 employees, it aims to provide customers with a seamless shopping experience driven by technology.
PepGen
Venture Round in 2021
PepGen Ltd. is a clinical-stage biotechnology company based in Oxford, United Kingdom, focused on advancing the next generation of nucleic acid therapeutics, particularly in the treatment of severe neuromuscular and neurologic diseases. Incorporated in 2018, PepGen has developed its Enhanced Delivery Oligonucleotide (EDO) platform, which is designed to improve the uptake and activity of conjugated oligonucleotide therapeutics. The company's innovative EDO peptides enhance tissue penetration, cellular uptake, and nuclear delivery, demonstrating their ability to transport oligonucleotides effectively into various target tissues, including smooth, skeletal, and cardiac muscle, as well as the central nervous system. PepGen aims to unlock the clinical potential of these transformative therapeutics, with a particular emphasis on the effective delivery of antisense oligonucleotides, and is advancing its novel conjugate therapeutics toward clinical application.
T-knife is a biotechnology company focused on developing T cell receptor therapies aimed at treating cancer. Utilizing a humanized T cell receptor (TCR) mice platform, the company is capable of carrying human TCRαβ gene loci and recombining a diverse array of human TCRs. This innovative approach facilitates the efficient generation and virtual selection of T cell receptors tailored for specific human tumor antigens, enhancing the potential for effective cancer therapies. Through its advanced technology, T-knife aims to improve treatment options for patients battling cancer.
QuantumScape is a renewable energy company focused on advancing solid-state battery technology to enhance the performance and range of electric vehicles. Founded in 2010 by Jagdeep Singh in San Jose, California, the company aims to transform the battery industry by creating a solid-state battery that offers significantly higher energy storage capacity compared to traditional batteries. QuantumScape is developing next-generation solid-state lithium-metal batteries, featuring an innovative anode-less cell design that improves energy density while reducing material costs and streamlining manufacturing processes. Through these advancements, QuantumScape seeks to facilitate the widespread adoption of electric vehicles.
Airtel Mobile Commerce BV
Secondary Market in 2021
Airtel Mobile Commerce BV is an Airtel Africa subsidiary that serves as the holding company for several of the company's mobile money operations in 14 African countries, including Kenya, Uganda, and Nigeria. The mobile money division runs one of the continent's largest financial services. It allows users to access mobile wallets, international money transfers, loans, and virtual credit cards.
impact.com
Venture Round in 2021
Impact is a marketing technology company that specializes in partnership automation, helping brands to enhance their paid marketing and media expenditures. Founded in 2008 in Santa Barbara, California, Impact has expanded to ten offices worldwide and employs over 400 individuals. The company's platform addresses marketers' needs for simplicity and transparency while enabling more effective media measurement, attribution, and optimization. By automating the full lifecycle of partnerships, Impact facilitates the discovery, recruitment, onboarding, engagement, and performance enhancement of various partnership types. Its solutions also focus on preventing ad fraud, thereby fostering informed decision-making. Impact serves a diverse range of global enterprises, including well-known brands, and seeks to drive revenue growth through innovative partnership strategies in the evolving Partnership Economy.
Flipkart
Private Equity Round in 2021
Flipkart is an Indian e-commerce marketplace offering over 30 million products across 70-plus categories, including books, electronics, home goods, and health care items. Headquartered in Bengaluru, it serves about 75 million registered users with around 10 million daily visits and ships roughly 8 million orders each month. Founded in 2007 by Binny and Sachin Bansal, Flipkart grew into a leading online retailer and was acquired by Walmart in 2018. The platform leverages technology and a large-scale logistics network to enable buyers and sellers to transact across a broad range of consumer goods.
Swiggy is a consumer-focused technology company offering an integrated app for food ordering, grocery shopping, restaurant reservations, and event bookings. It facilitates doorstep delivery of these items via its network of on-demand delivery partners.
Age of Learning
Series C in 2021
Age of Learning, Inc., based in Glendale, California, is a prominent education technology company known for its flagship product, ABCmouse.com Early Learning Academy, which caters to children aged 2 to 7. The platform offers a comprehensive curriculum that includes subjects such as reading, math, science, and art, designed to foster a strong academic foundation and a love for learning. Age of Learning also provides specialized programs for schools, including ABCmouse.com for Schools, which offers free access to educators and their students, allowing for individualized lessons aligned with educational standards. Additionally, the company supports early childhood education initiatives through its Head Start program for low-income families and partnerships with public libraries to provide free access to its resources. With over 11 billion learning activities completed by more than 50 million children globally, Age of Learning is dedicated to enhancing educational equity and access while promoting engagement through interactive features and rewards.
Thumbtack
Series I in 2021
Thumbtack is an online services marketplace that connects homeowners with local professionals across categories including movers and packers, contractors, plumbers, roofers, cleaners, handymen, attorneys, web designers, application developers, personal trainers, electricians, landscapers, and photographers. It provides personalized guidance on what to do and when to do it, and recommendations on who to hire from a large community of service providers, enabling homeowners to manage and complete home projects by hiring the right professionals. Founded in 2008 and based in San Francisco, Thumbtack helps users plan, manage, and execute home improvement, repair, and everyday service needs.
Bright Peak Therapeutics
Series B in 2021
Bright Peak Therapeutics is a biotechnology company focused on developing a range of immunotherapies aimed at treating cancer and autoimmune diseases. The company specializes in creating immuno-cytokines that possess pharmacological properties enabling tissue and cell-specific targeting of cytokine payloads. This innovative approach is designed to enhance the efficacy of treatments, ultimately improving patient outcomes and quality of life. By leveraging its expertise in cytokine therapeutics, Bright Peak aims to advance the field of immunotherapy and provide effective solutions for challenging medical conditions.
Swiggy is a consumer-focused technology company offering an integrated app for food ordering, grocery shopping, restaurant reservations, and event bookings. It facilitates doorstep delivery of these items via its network of on-demand delivery partners.
Entrada Therapeutics
Series B in 2021
Entrada Therapeutics, Inc. is a clinical-stage biotechnology company based in Boston, Massachusetts, focused on treating diseases through the intracellular delivery of biologics. Founded in 2016, the company has developed innovative technologies that facilitate the efficient delivery of proteins, peptides, and nucleic acids, targeting intracellular sites that have traditionally been difficult to access. Entrada's approach includes Intracellular Enzyme Replacement Therapy (IC-ERT) and Endosomal Escape Vehicle (EEV) therapeutics, which aim to improve the therapeutic index by enabling the delivery of a wide range of therapeutics across various organs and tissues. The company's pipeline addresses conditions related to neuromuscular diseases and expands into additional therapeutic areas, positioning Entrada at the forefront of advancing treatment options for patients with devastating illnesses.
OncoResponse
Series C in 2021
OncoResponse is an immuno‑oncology biotechnology company that uses a proprietary human antibody platform to discover novel targets and develop fully human monoclonal antibodies for cancer treatment. By interrogating the adaptive immune system of patients who respond exceptionally well to checkpoint inhibition, the company identifies genuine human antibodies against high‑value targets linked with immunosuppressive myeloid biology. Its pipeline aims to alleviate tumor‑microenvironment immunosuppression and enhance immune activation, converting cold tumors into hot ones and providing new therapeutic options for patients.
Siemens Healthineers
Post in 2021
Siemens Healthineers AG is a healthcare technology company that develops, manufactures, and distributes a wide range of imaging, diagnostic, and advanced therapy products and services globally. It operates through three main segments: Imaging, Diagnostics, and Advanced Therapies. The Imaging segment includes technologies such as magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services, covering laboratory, molecular, and point-of-care diagnostics, alongside workflow solutions and informatics. The Advanced Therapies segment focuses on integrated solutions for therapy departments, featuring products like angiography systems and robotic-assisted platforms for vascular interventions. Additionally, Siemens Healthineers provides customer services such as design, maintenance, operational management, training, and education, along with digital health solutions. The company is headquartered in Erlangen, Germany, and operates as a subsidiary of Siemens Aktiengesellschaft.
Eat Just
Venture Round in 2021
Eat Just, Inc., founded in 2011 and based in San Francisco, California, focuses on creating plant-based food products aimed at improving the food system. The company offers a variety of items, including plant-based scrambled eggs, flavored mayonnaise, dressings, cookie doughs, and meat alternatives. Their flagship product, JUST Egg, has garnered significant recognition, being featured in lists such as Popular Science's "100 Greatest Innovations." Eat Just emphasizes innovation through a unique discovery platform for food ingredients, combining scientific research with culinary expertise from Michelin-starred chefs. The company has been acknowledged in various prestigious lists, including Fast Company’s "Most Innovative Companies" and Entrepreneur’s "100 Brilliant Companies."
Starling Bank
Series D in 2021
Starling Bank Limited is a digital-only bank based in London, United Kingdom, founded in 2014. It specializes in providing personal, joint, and business banking services through a mobile platform. The bank offers a range of financial services, including digital banking, real-time spending intelligence, and personalized banking options. Customers can manage their accounts entirely online, benefiting from features such as same-day payments and comprehensive financial management tools. Starling Bank aims to facilitate a seamless, paperless banking experience for its users.
Century Therapeutics
Series C in 2021
Century Therapeutics, Inc. is a biotechnology company focused on developing innovative cell therapies derived from induced pluripotent stem cells (iPSCs) to treat hematologic and solid malignancies. Founded in 2018 and headquartered in Philadelphia, Pennsylvania, the company utilizes a specialized platform that integrates gene editing and protein engineering to create allogeneic therapies. This platform allows for the generation of master cell banks of modified immune effector cells, specifically engineered to optimize performance and reduce the risk of rejection by the host immune system. By employing advanced technologies such as CRISPR-mediated gene editing and proprietary chimeric antigen receptors, Century Therapeutics aims to address significant unmet medical needs in cancer and other diseases.
VerSe Innovation
Series H in 2021
VerSe Innovation is a local language technology company that develops a discovery platform to consume and socialize with media. Its platform facilitates the curation of content and tracks user preferences through its vertical search and recommendation tools that provide users with personalized content and notifications.
Tessera Therapeutics
Series B in 2021
Tessera Therapeutics is an early-stage life sciences company focused on pioneering Gene Writing technology, which allows for the precise insertion of therapeutic messages into the human genome. This innovative approach aims to address diseases at their source by enabling both small and large genetic alterations. By building on recent advancements in gene therapy and gene editing, Tessera Therapeutics seeks to overcome existing limitations in these fields, enhancing their efficacy and reach. Founded by Flagship Pioneering, the company aspires to establish a new category in genetic medicine that can significantly improve patient outcomes and transform healthcare.
Paycor
Private Equity Round in 2021
Paycor, Inc. is a provider of cloud-based human resource, payroll, and timekeeping software solutions tailored for small and mid-sized businesses in the United States. Established in 1990 and headquartered in Cincinnati, Ohio, the company offers a range of products including a web-based solution for recruiting, onboarding, HR and benefits administration, payroll and tax compliance, as well as time and attendance tracking. Additionally, Paycor features a Learning Management System that integrates various training modalities and a data visualization tool called Workforce Insights, which helps businesses derive actionable insights from their workforce data. The company aims to enhance operational efficiency and facilitate informed decision-making for entrepreneurs, financial professionals, and HR specialists. With facilities across several states, including Alabama, Indiana, California, Kentucky, Maryland, Pennsylvania, and Michigan, Paycor is committed to optimizing people management for its clients.
Fluence
Private Equity Round in 2020
Fluence specializes in energy storage technology solutions and services, providing advanced systems for the efficient management of energy resources. The company focuses on optimizing energy storage to enhance the reliability and sustainability of power systems. By offering innovative technology and services, Fluence helps utilities, commercial businesses, and other energy stakeholders integrate renewable energy sources, improve grid stability, and reduce costs associated with energy management. Through its sophisticated energy storage solutions, Fluence aims to facilitate the transition to a cleaner energy future, supporting the growing demand for reliable and sustainable energy systems worldwide.
Transcenta Holding
Series C in 2020
Transcenta Holding Ltd. is a clinical-stage biotherapeutics company focused on the research, development, and manufacturing of antibody-based therapeutics. Established in 2019 and headquartered in Suzhou, China, the company operates additional facilities in Shanghai, Hangzhou, Beijing, Waltham, and Princeton. Transcenta's integrated approach encompasses the discovery and development of innovative antibodies aimed at addressing various medical conditions, particularly in oncology and specific non-oncology areas such as bone and kidney disorders. The company is currently advancing nine therapeutic antibody molecules through clinical development, underscoring its commitment to improving patient outcomes. Transcenta was formed through the merger of HJB and MabSpace Biosciences, positioning it as a significant player in the global biopharmaceutical landscape.
Inigo
Private Equity Round in 2020
Inigo Limited is a specialty insurance and re-insurance company incorporated in 2020 and based in Bracknell, United Kingdom. The company provides a range of insurance products, with offerings in property, terrorism and political violence, and financial lines and casualty insurance categories. By operating as a specialty insurer, Inigo seeks to underwrite a streamlined portfolio of insurance and re-insurance risks, thereby assisting commercial and industrial companies in making informed decisions.
Xpeng Motors
Series C in 2020
Xpeng Motors is a Chinese electric vehicle and technology company that specializes in the design and manufacture of smart cars. The company emphasizes local market needs and prioritizes consumer experience, integrating advanced autonomous driving features and internet-connected technologies into its vehicles. This approach aims to enhance the overall functionality and appeal of their cars, making them more than just traditional vehicles. Additionally, Xpeng Motors has a subsidiary, Xpeng Robotics, which focuses on developing smart robots as part of its broader mobility ecosystem.
Praxis Precision Medicines
Series C in 2020
Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders marked by neuronal imbalance. Established in 2015 and headquartered in Cambridge, Massachusetts, the company leverages genetic insights to create innovative treatments for neurological and psychiatric conditions. Its leading product candidates include PRAX-114, an allosteric modulator targeting GABAA receptors, currently undergoing Phase IIa trials for major depressive disorder and perimenopausal depression, and PRAX-944, a selective inhibitor of T-type calcium channels in Phase IIa trials for essential tremor. Additionally, Praxis is advancing PRAX-562, a sodium current blocker in Phase I trials for severe pediatric epilepsy and adult cephalgia, along with PRAX-222, an antisense oligonucleotide aimed at treating patients with SCN2A epilepsy, and a program focused on KCNT1-related epilepsy. The company has established collaborations and licensing agreements with various organizations to enhance its research and development efforts.
Traveloka
Venture Round in 2020
Traveloka is an online travel aggregator based in Indonesia, primarily focused on helping customers search for and book various travel options. It operates a comprehensive platform that enables users to compare and book flights, hotels, villas, apartments, transportation, tours, holiday packages, and activities. By providing a user-friendly search engine, Traveloka aims to simplify the travel planning process, allowing individuals to find accommodations and tickets that meet their specific needs. The company has expanded its operations to six countries and continues to explore new initiatives to enhance its impact in the travel industry.
CureVac
Venture Round in 2020
CureVac is a biopharmaceutical company developing transformative medicines using messenger RNA (mRNA). Its product pipeline includes cancer immunotherapies, prophylactic vaccines against infectious diseases, molecular therapies for various indications, and mRNA-encoded antibodies.
Zuoyebang
Series E in 2020
Zuoyebang is an online education startup based in Beijing, China, founded in 2014 by Hou Jianbin. The company offers a web and mobile learning platform tailored for primary and high school students, providing a range of educational products and services. Its platform leverages artificial intelligence to allow students to upload homework questions and search for answers to their academic queries. In addition to homework assistance, Zuoyebang offers online courses, live lessons, and evaluations for students from kindergarten through 12th grade. The company has garnered significant backing from prominent investors, including Baidu, Alibaba Group, Tiger Global Management, SoftBank Vision Fund, Sequoia Capital China, and FountainVest Partners.
Tandem
Venture Round in 2020
Tandem is a digital bank that aims to provide a better banking experience by leveraging technology and user feedback. It offers a range of financial services, including savings accounts, credit cards, and loans, all managed through a user-friendly mobile app. Tandem's approach is centered around simplicity, with a focus on helping users save money and reducing financial stress. It differentiates itself by actively engaging with its user community to inform product development and improvement.
Califia Farms
Series D in 2020
Califia Farms, LLC is a manufacturer of plant-based food and beverages based in Los Angeles, California. Founded in 2010, the company specializes in a range of products including cold brew coffee, plant milks, creamers, yogurts, juices, and protein oats. Califia Farms emphasizes the use of California-grown fruits and nuts, promoting wellness through its innovative offerings that are free from artificial ingredients and carrageenan. The company's mission is to provide delicious and mindful nourishment, and its products are available through various retail outlets and online grocery platforms. The brand name, inspired by the Spanish legend of warrior queen Califia, reflects a commitment to quality and sustainability in its beverage production.
Adani Electricity
Private Equity Round in 2020
The Adani Group is a globally integrated infrastructure player with business spanning across key industry verticals of resources, logistics, energy and agro. The Adani Group's growth and vision has always been in sync with the idea of Nation Building. "Thinking Big. Doing Better" is a natural philosophy that is embodied in everyone at Adani Group and they sincerely believe that they are doing their part in nation building and touching the lives of millions of people positively.
Adani Electricity Mumbai Limited (AEML) is a 100% subsidiary of Adani Transmission Ltd, formed post acquisition of Reliance Infrastructure Limited's integrated Generation, Transmission and Distribution utilities powering Mumbai city.
As an organization, they believe in The Power of Service. It is born of the will to make a difference. They change things for the better, and you can power your dreams and live stress-free life.
Their distribution network spans over 400 Sq. kms catering to the electricity needs of over 2.9 million customers today. The area in Suburban Mumbai served by AEML is from Bandra to Bhayander on the western side, and Sion to Mankhurd on the eastern Side.
Founded in 2012, Compass is a real estate technology company that provides an online platform for buying, renting, and selling properties. Its end-to-end platform supports the entire transaction workflow by pairing industry talent with technology to create intelligent and seamless experiences. Compass operates across multiple regions in the United States.
BYJU'S
Private Equity Round in 2019
BYJU'S is a prominent global ed-tech company founded in India in 2011, dedicated to providing adaptive and engaging learning solutions to over 150 million students worldwide. The company aims to make high-quality education accessible to learners of all ages through its flagship product, BYJU's: The Learning App, and a diverse portfolio that includes brands such as Disney-BYJU's Early Learn, BYJU's FutureSchool, and WhiteHat Jr. BYJU'S employs personalized learning methodologies that cater to individual learning styles and paces, supported by a network of over 12,000 teachers. The platform utilizes original content, watch-and-learn videos, animations, and interactive simulations to create a contextual and practical learning experience. Additionally, BYJU'S has formed innovative partnerships with major companies like Disney and Google to enhance engagement. Headquartered in India, BYJU'S operates in more than 21 countries and offers programs in over 8 languages, further solidifying its position as a leader in the education technology sector.
SoFi
Private Equity Round in 2019
SoFi is a San Francisco–based financial services company offering lending, banking, and wealth management products designed to help individuals borrow, save, spend, and invest. Its offerings include personal loans, MBA and student loan refinancing, mortgages, checking and savings accounts, and credit cards, as well as investment and retirement planning services. The company also provides small business financing as part of its product suite. By combining digital tools with traditional financial services, SoFi targets early-stage professionals seeking to manage debt, build savings, and pursue long-term financial goals.
Super Home Inc. offers a subscription-based service designed to assist homeowners with care and repair for their properties. Founded in 2014 and headquartered in San Francisco, California, the company serves members in Washington, DC, and Maryland. Super provides coverage for repairs and replacements of appliances and home systems that experience breakdowns. Users can conveniently access services through various devices, including desktop and mobile platforms. Additionally, Super's maintenance schedule helps homeowners understand their property's needs, ensuring they receive timely assistance without incurring high costs.
Airtel Africa
Funding Round in 2019
Airtel Africa is a telecommunications company offering mobile voice and data services across Nigeria, East Africa, and Francophone Africa. As of March 2020, it served approximately 110.6 million customers with prepaid/postpaid wireless voice, data communication services, and mobile money services.
Lufax is a technology-driven personal financial services platform in China, operating as an associate company of Ping An Insurance. It specializes in wealth management solutions for China's middle class and affluent population, along with retail credit facilitation services.
Founded in 2012, Compass is a real estate technology company that provides an online platform for buying, renting, and selling properties. Its end-to-end platform supports the entire transaction workflow by pairing industry talent with technology to create intelligent and seamless experiences. Compass operates across multiple regions in the United States.